Hostname: page-component-cd9895bd7-gbm5v Total loading time: 0 Render date: 2024-12-25T16:34:56.163Z Has data issue: false hasContentIssue false
  • English
  • Français

Asociación entre el tratamiento de flupentixol y la emergencia de síntomas maníacos

Published online by Cambridge University Press:  12 May 2020

D. Becker ,
Y. Grinberg ,
A. Weizman  and
R. Mester
D. Becker
Affiliation:
Centro de Salud Mental de Ness-Ziona, Ness-Ziona, P.O. Box 1, Ness-Ziona 74450, Israel
Y. Grinberg
Affiliation:
Centro de Salud Mental de Ness-Ziona, Ness-Ziona, P.O. Box 1, Ness-Ziona 74450, Israel
A. Weizman
Affiliation:
Hospital Psiquiátrico Geha, Centro Médico Rabin, Petah Tiqva y Facultad Sackler de Medicina, Universidad de Tel Aviv, Tel Aviv, Israel
R. Mester
Affiliation:
Centro de Salud Mental de Ness-Ziona, Ness-Ziona, P.O. Box 1, Ness-Ziona 74450, Israel
Get access

Resumen

Antecedentes:

El flupentixol es un medicamento antipsicótico con conocidas propiedades elevadoras del estado de ánimo. Su propensión a inducir síntomas maníacos no se ha investigado.

Métodos y resultados:

Describimos seis pacientes, cuatro con esquizofrenia y dos con trastorno bipolar, en los que el tratamiento de flupentixol se asoció con la emergencia de síntomas maníacos.

Conclusiones:

Se debería vigilar cuidadosamente a los pacientes tratados con flupentixol en cuanto a la emergencia de síntomas maníacos.

Keywords

flupentixolmaníaantipsicótico
Type
Artículo original
Information
European Psychiatry (Ed. Española) , Volume 10 , Issue 3 , April 2003 , pp. 156 - 160
Copyright
Copyright © European Psychiatric Association 2003

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bibliografía

Dwight, MM, Keck, PE, Stanton, SP, Strakowski, SM, McElroy, SI. Antidepressant activity and manía associated with risperidone treatment of schizoaffective disorder. Lancet 1994; 344:554–5.CrossRefGoogle ScholarPubMed
Hamilton, M, Card, IR, Wallis, GG, Mahmoud, MK. A comparative trial of the decanoates of flupenthixol and fluphenazine. Psychopharmacology 1979;64:225–9.CrossRefGoogle ScholarPubMed
Hsien-Yuan, L, Yui-Ching, L, Wen-Ho, C. Mania induced by risperidone: cose related? J Clin Psychiatry 1998;59:85.Google Scholar
Kelly, HR, Freeman, HC, Bannig, B, Schiff, AA. Clinical and social comparison of fluphenazine decanoate and flupenthixol decanoate in the community maintenance therapy of schizophrenia. Int Pharmacopsychiatry 1977;12:54–64.CrossRefGoogle ScholarPubMed
Szabo, CP. Depot flupenthixol-induced mania. S Afr Med J 1993;83:442.Google ScholarPubMed
Trueman, AR, Valentine, MG. Flupenthixol decanoate in schizophrenia. Br J Psychiatry 1974;124:58–9.CrossRefGoogle Scholar
Wistedt, B, Ranata, J. A comnarative double-blind study of flupenthixol decanoate and fluphenazine decanoate in the treatment of patient relapsing in schizophrenia symptomatology. Acta Psychiatr Scand 1983;67:378–88.CrossRefGoogle Scholar
Young, JPR, Hughes, WC, Lader, MH. A controlled comparison of flupenthixol and amitriptyline in depressed outpatients. Br Med J 1976;1:1116–8.CrossRefGoogle ScholarPubMed
Zolezzi, M, Ghany Badr, MGA. Risperidone-induced mania. Ann Pharmacother 1999;33:380.CrossRefGoogle ScholarPubMed